Association between serum fibroblast growth factor-23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease.
Hirosumi MiyakawaHuai-Hsun HsuMizuki OgawaRyota AkabaneYuichi MiyagawaNaoyuki TakemuraPublished in: Journal of veterinary internal medicine (2021)
Increased FGF-23 concentration in normophosphatemic dogs with CKD was associated with significant risk of development of hyperphosphatemia, independent of CKD stage, and of the progression of CKD. Future research focusing on whether interventions that decrease FGF-23 secretion will slow the development of hyperphosphatemia and CKD progression is needed.